Genome-wide assessment of Parkinson's disease in a Southern Spanish population
暂无分享,去创建一个
D. Hernandez | M. Nalls | T. Price | A. Singleton | B. Gutiérrez | S. Arepalli | S. Bandres-Ciga | F. Barrero | F. Escamilla-Sevilla | F. Vives | R. Durán | J. Cervilla | M. Rivera | Alberto M. Rivera | Javier Pelegrina | Jing Ding
[1] Francisco Vives,et al. Analysis of the genetic variability in Parkinson's disease from Southern Spain , 2016, Neurobiology of Aging.
[2] Margaret Sutherland,et al. Diagnosis of Parkinson's disease on the basis of clinical and genetic classification: a population-based modelling study , 2015, The Lancet Neurology.
[3] H. Stefánsson,et al. Heterozygote carriers for CNVs in PARK2 are at increased risk of Parkinson's disease. , 2015, Human molecular genetics.
[4] J. Olsen,et al. Impact of Parkinson's disease risk loci on age at onset , 2015, Movement disorders : official journal of the Movement Disorder Society.
[5] Valentina Escott-Price,et al. Genetic risk and age in Parkinson's disease: Continuum not stratum , 2015, Movement disorders : official journal of the Movement Disorder Society.
[6] M. Nalls,et al. Polygenic risk of Parkinson disease is correlated with disease age at onset , 2015, Annals of neurology.
[7] Nicholas Eriksson,et al. NeuroX, a fast and efficient genotyping platform for investigation of neurodegenerative diseases , 2015, Neurobiology of Aging.
[8] Chuong B. Do,et al. Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson’s disease , 2014, Nature Genetics.
[9] Hannah A. Pliner,et al. Assessment of Parkinson's disease risk loci in Greece , 2014, Neurobiology of Aging.
[10] Vladimir Makarov,et al. The Sac1 Domain of SYNJ1 Identified Mutated in a Family with Early‐Onset Progressive Parkinsonism with Generalized Seizures , 2013, Human mutation.
[11] E. Dietrichs,et al. Supportive evidence for 11 loci from genome-wide association studies in Parkinson's disease , 2013, Neurobiology of Aging.
[12] Mohamad Saad,et al. Using genome-wide complex trait analysis to quantify 'missing heritability' in Parkinson's disease. , 2013, Human molecular genetics.
[13] J. Hardy,et al. The glucocerobrosidase E326K variant predisposes to Parkinson's disease, but does not cause Gaucher's disease , 2013, Movement disorders : official journal of the Movement Disorder Society.
[14] M. Rieder,et al. Optimal unified approach for rare-variant association testing with application to small-sample case-control whole-exome sequencing studies. , 2012, American journal of human genetics.
[15] D. Hernandez,et al. Genome Wide Assessment of Young Onset Parkinson’s Disease from Finland , 2012, PloS one.
[16] Eden R Martin,et al. Meta‐analysis of Parkinson's Disease: Identification of a novel locus, RIT2 , 2012, Annals of neurology.
[17] Chuong B. Do,et al. Comprehensive Research Synopsis and Systematic Meta-Analyses in Parkinson's Disease Genetics: The PDGene Database , 2012, PLoS genetics.
[18] M. Farrer,et al. VPS35 mutations in Parkinson disease. , 2011, American journal of human genetics.
[19] Marc N. Offman,et al. A mutation in VPS35, encoding a subunit of the retromer complex, causes late-onset Parkinson disease. , 2011, American journal of human genetics.
[20] Simon C. Potter,et al. A Two-Stage Meta-Analysis Identifies Several New Loci for Parkinson's Disease , 2011, PLoS genetics.
[21] D. Hernandez,et al. Genome-wide association study confirms extant PD risk loci among the Dutch , 2011, European Journal of Human Genetics.
[22] Nicholas Eriksson,et al. Web-Based Genome-Wide Association Study Identifies Two Novel Loci and a Substantial Genetic Component for Parkinson's Disease , 2011, PLoS genetics.
[23] Mohamad Saad,et al. Imputation of sequence variants for identification of genetic risks for Parkinson's disease: a meta-analysis of genome-wide association studies , 2011, The Lancet.
[24] Mohamad Saad,et al. Genome-wide association study confirms BST1 and suggests a locus on 12q24 as the risk loci for Parkinson's disease in the European population. , 2011, Human molecular genetics.
[25] P. Visscher,et al. GCTA: a tool for genome-wide complex trait analysis. , 2011, American journal of human genetics.
[26] A. Singleton,et al. Towards a complete resolution of the genetic architecture of disease. , 2010, Trends in genetics : TIG.
[27] G. Schellenberg,et al. A comprehensive analysis of deletions, multiplications, and copy number variations in PARK2 , 2010, Neurology.
[28] J. Nutt,et al. Common genetic variation in the HLA region is associated with late-onset sporadic Parkinson’s disease , 2010, Nature Genetics.
[29] Eden R Martin,et al. Genome‐Wide Association Study Confirms SNPs in SNCA and the MAPT Region as Common Risk Factors for Parkinson Disease , 2010, Annals of human genetics.
[30] Yusuke Nakamura,et al. Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson's disease , 2009, Nature Genetics.
[31] Sonja W. Scholz,et al. Genome-Wide Association Study reveals genetic risk underlying Parkinson’s disease , 2009, Nature Genetics.
[32] M. Nalls,et al. Multicenter analysis of glucocerebrosidase mutations in Parkinson's disease. , 2009, The New England journal of medicine.
[33] M. Ronaghi,et al. Genome-wide linkage analysis of a Parkinsonian-pyramidal syndrome pedigree by 500 K SNP arrays. , 2008, American journal of human genetics.
[34] C. Lautier,et al. Mutations in the GIGYF2 (TNRC15) gene at the PARK11 locus in familial Parkinson disease. , 2008, American journal of human genetics.
[35] Sonja W. Scholz,et al. Structural genomic variation in ischemic stroke , 2008, Neurogenetics.
[36] Manuel A. R. Ferreira,et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. , 2007, American journal of human genetics.
[37] Sonja W. Scholz,et al. Genome-wide genotyping in Parkinson's disease and neurologically normal controls: first stage analysis and public release of data , 2006, The Lancet Neurology.
[38] Andrew Lees,et al. Cloning of the Gene Containing Mutations that Cause PARK8-Linked Parkinson's Disease , 2004, Neuron.
[39] Thomas Meitinger,et al. Mutations in LRRK2 Cause Autosomal-Dominant Parkinsonism with Pleomorphic Pathology , 2004, Neuron.
[40] R. Nussbaum,et al. Hereditary Early-Onset Parkinson's Disease Caused by Mutations in PINK1 , 2004, Science.
[41] Toshihiro Tanaka. The International HapMap Project , 2003, Nature.
[42] Patrizia Rizzu,et al. Mutations in the DJ-1 Gene Associated with Autosomal Recessive Early-Onset Parkinsonism , 2002, Science.
[43] E. Lander,et al. On the allelic spectrum of human disease. , 2001, Trends in genetics : TIG.
[44] S. Minoshima,et al. Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism , 1998, Nature.
[45] Robert L. Nussbaum,et al. Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease , 1997 .
[46] J. Stockman. Multicenter Analysis of Glucocerebrosidase Mutations in Parkinson's Disease , 2011 .
[47] S. Gilman,et al. Diagnostic criteria for Parkinson disease. , 1999, Archives of neurology.